Recent Finacing
Recent Raise
NETRIS Pharma is a clinical-stage biotechnology company developing therapies that target the netrin-1/dependence receptor axis to overcome cancer treatment resistance.
Focus Areas
Recent Investors
Total Raised
Funding rounds
Investor
See the team members at NETRIS Pharma.
